Home Contact Site Map Search Submit Value through Innovation 14 March 2021 Media Centre Corporate Profile Global Activities Corporate Responsibility Careers Research & Development Clinical Trials Medical Information Products Partnering Boehringer Ingelheim Resource for Journalists Our Global Activities Our Countries A-Z for US residents Boehringer Ingelheim Statement Boehringer Ingelheim Statement on Agreement to Sell Roxane Labs to Hikma Pharmaceuticals PLC Latest Press Releases 29.09.2015 New data demonstrate sustained long-term efficacy of OFEV®* on slowing disease progression and safety in patients with IPF 28.09.2015 COPD: New data support role of Spiolto® Respimat® as 1st-line maintenance therapy and show superiority over LABA/ICS 27.09.2015 VARGATEF® plus docetaxel significantly reduced tumour burden in lung cancer patients with advanced adenocarcinoma compared to docetaxel alone 27.09.2015 ECC 2015: GIOTRIF® (afatinib) demonstrates superior survival compared to Tarceva® (erlotinib) for patients with previously treated advanced squamous cell carcinoma of the lung, independent of EGFR mutation status 25.09.2015 CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®) Further press releases Biopharmaceuticals Manufacturing. Solutions. Partnering with us Working together Partnership with Ashoka Making More Health Activities back to top Connect with us Facebook - Company Page Instagram Linkedin Pinterest - Online Pinboard Twitter - Global Channel YouTube - Our Video Channels Mobile Website Job Search Accessibility Statement Terms of use Imprint RSS Feed Print Page Recommend © 2010 - 2021 Boehringer Ingelheim GmbH All rights reserved

Disclaimer Using this link will let you leave a website of Boehringer Ingelheim GmbH. The linked site is not under the control of Boehringer Ingelheim GmbH and Boehringer Ingelheim GmbH shall not be responsible for the contents of any linked site or any link contained in a linked site, or any changes or updates to such sites. Neither is Boehringer Ingelheim GmbH responsible for webcasting or any other form of transmission received from any linked site. This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by Boehringer Ingelheim GmbH of the site. Continue © 2010 - 2021 Boehringer Ingelheim GmbH All rights reserved RSS Feed Print Page